Sana biotechnology stock.
Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed.
Feb-10-23 08:18AM. Insiders who purchased this year lose US$82k as Sana Biotechnology, Inc. (NASDAQ:SANA) stock drops to US$4.36. (Simply Wall St.) Feb-02-23 04:05PM. Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference.Get the latest stock price, quote, news and history of Sana Biotechnology, Inc. Common Stock (SANA), a biotechnology company that develops and commercializes products for the treatment of cancer and other diseases. See real-time data, market cap, key data and news of SANA on Nasdaq.The company, currently valued at $43.28M, closed the last trade at $0.21 per share which meant it gained $0.01 on the day or 3.08% during that session. The BHIL stock price is -1376.19% off its 52-week high price of $3.10 and 33.33% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that ...Apr 14, 2023 · Shares of Sana Biotechnology ( SANA -1.18%) rose 49.4% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence. The biotech company's stock rose on news ...
Q3 2022 cash position of $511.6 million. Expect cash runway into 2025. SEATTLE, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and ...Sana stock up on peer-reviewed data on drug technology (NASDAQ:SANA) From Seeking Alpha Apr 13, 2023. Sana Biotechnology (SANA) added ~29% Thursday after announcing peer-reviewed data on ...
Q4 2022 cash position of $434.0 million. Current cash position enables for runway into 2025. SEATTLE, March 16, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused ...
SANA Stock 12 Months Forecast. $9.67. (130.24% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Sana Biotechnology in the last 3 months. The average price target is $9.67 with a high forecast of $13.00 and a low forecast of $8.00. The average price target represents a 130.24% change from the last price of $4.20.News Releases Dec 01, 2023 Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune …Dr. Douglas E. Williams as Head of Research and Development Dr. Gary Meininger as Chief Medical Officer SEATTLE, April 10, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...
Sana Biotechnology, an unusually heavily financed cell and gene therapy developer run by former Juno Therapeutics executives, has raised $588 million in an initial public offering, a strong sign that interest in emerging biotechs hasn’t waned after a record-setting 2020. The Seattle-based biotech sold 23.5 million shares at $25 apiece, well ...
Sep 26, 2023 · Sana Biotechnology, Inc. (NASDAQ:SANA) has recently received an average rating of “Hold” from five research firms that cover the stock, according to Bloomberg Ratings. Among these firms, three analysts have given a hold rating, while two have recommended buying the company’s shares.
The latest price target for Sana Biotechnology ( NASDAQ: SANA) was reported by JMP Securities on Thursday, October 12, 2023. The analyst firm set a price target for 8.00 expecting SANA to rise to ...OCGN stock was always an extremely speculative bet. But with the coronavirus destroying sentiment, the dangers have been amplified. The risk-reward picture for OCGN stock is ridiculously tilted Among currently trending biotechnology firms, ...Complete Sana Biotechnology Inc. stock information by Barron's. View real-time SANA stock price and news, along with industry-best analysis.The Sana stock price is currently $4.76. The above agreements are part and parcel for many biotech startups, but investors need to consider what they mean as they may significantly dent their upside.Sana Biotechnology is growing, and we are hiring new team members who believe in the potential of engineered cells as medicines, who want to challenge status quo, and who lead with the desire to ...
Sana Biotechnology, Inc. SEATTLE, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today ...Track Sana Biotechnology Inc (SANA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the Conversation! Build your trading network;The company, currently valued at $163.76M, closed the last trade at $1.44 per share which meant it gained $0.11 on the day or 8.27% during that session. The ESPR stock price is -515.97% off its 52-week high price of $8.87 and 51.39% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find …Get the latest stock price, quote, news and history of Sana Biotechnology, Inc. Common Stock (SANA), a biotechnology company that develops and commercializes products for the treatment of cancer and other diseases. See real-time data, market cap, key data and news of SANA on Nasdaq.Shares of Sana Biotechnology ( SANA -1.18%) rose 49.4% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence. The biotech company's stock rose on news ...The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotechnologies accelerates the critical but sl...
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, and genetic disorders, among ...Sana priced its upsized offering of 23.5 million shares at $25 apiece. That’s significantly more than the biotech initially planned. When it set the terms of the offering last week, it projected ...
The latest Sana Biotechnology stock prices, stock quotes, news, and SANA history to help you invest and trade smarter.Get the latest stock price, quote, news and history of Sana Biotechnology, Inc. Common Stock (SANA), a biotechnology company that develops and …News Releases. SEATTLE, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in November and December. Goal is to report UP421 proof of …What's Happening With Sana Biotechnology Inc Stock Today? Sana Biotechnology Inc (SANA) stock has risen 3.47% while the S&P 500 is lower by -0.7% as of 1:01 PM on Friday, Apr 14. SANA has risen $0.17 from the previous closing price of $4.90 on volume of 1,193,832 shares. Over the past year the S&P 500 has fallen -6.27% while SANA is lower by ...Find the latest Institutional Holdings data for Sana Biotechnology, Inc. Common Stock (SANA) at Nasdaq.com.SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) --Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to initiate a first-in-human study of SC291 in …
Seattle-based Sana went public just as the biotech stock market peaked in February 2021, enabling it to raise $587.5 million before entering the clinic. The stock has followed the broader market ...
Follow. SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the ...
Get the latest stock price, quote, news and history of Sana Biotechnology, Inc. Common Stock (SANA), a biotechnology company that develops and …Apr 13, 2023 · SANA Price Action: Sana Biotechnology has a 52-week high of 9.59 and a 52-week low of $2.99. Sana Biotechnology shares are up 26.4% at $4.74 at the time of writing, according to Benzinga Pro ... SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results and business highlights for the first quarter 2023. ... Washington, and other allocated costs. Research and development expenses include …We never lose sight of why our work matters – the potential to impact the lives of patients is important to everyone at Sana. We are advancing a number of innovative drug candidates with the goal of disrupting the possible for patients across a diverse set of diseases. Pipeline. The most advanced programs include an allogeneic CAR T program ... Sana Biotechnology ( SANA – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Emily Bodnar today. The company’s shares closed yesterday at $5.47. According ...Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates. ... 2022 include non-cash stock-based compensation of $7.4 million and $13.1 million, respectively, and $3.1 ...Sana Biotechnology has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Cabaletta Bio has a beta of 2.5, suggesting that its stock price is 150% more volatile than the S&P 500.The Sana Biotechnology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human …The week that ended April 14 was a good one for markets overall and a great one for two stocks in the healthcare sector. Sana Biotechnology jumped 58% higher last week as investors cheered ...The Sana Biotechnology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at …Feb-10-23 08:18AM. Insiders who purchased this year lose US$82k as Sana Biotechnology, Inc. (NASDAQ:SANA) stock drops to US$4.36. (Simply Wall St.) Feb-02-23 04:05PM. Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference.
Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting. SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that five abstracts will have poster …Follow. SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the ...Sana Biotechnology Inc (SANA) stock is trading at $3.58 as of 11:15 AM on Monday, Dec 4, a decline of -$0.46, or -11.39% from the previous closing price of $4.04. …Akero Therapeutics Inc. 16.10. -0.24. -1.47%. Get Sana Biotechnology Inc (SANA:NASDAQ) real-time stock quotes, news, price and financial information from …Instagram:https://instagram. adhgbest mobile bank accounttrading practice sitesbest online day trading platform Akero Therapeutics Inc. 16.10. -0.24. -1.47%. Get Sana Biotechnology Inc (SANA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Aug 1, 2023 · The net loss for the quarter was $82.1 million, up from $31.4 million in the same period in 2022. Per Seeking Alpha data: SANA's stock shows mixed momentum over various time frames. Over the last ... lightspeed broker reviewrecommended gold stocks May 24, 2023 · In a report released today, Emily Bodnar from H.C. Wainwright reiterated a Hold rating on Sana Biotechnology ( SANA – Research Report ). The company’s shares closed yesterday at $7.09. Bodnar ... analyst price Seattle-based Sana went public just as the biotech stock market peaked in February 2021, enabling it to raise $587.5 million before entering the clinic. The stock has followed the broader market ...SEATTLE, Dec. 11, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, shared data in six presentations at ...Discover historical prices for SANA stock on Yahoo Finance. View daily, weekly or monthly format back to when Sana Biotechnology, Inc. stock was issued.